← FDA Drug Approvals (Drugs@FDA)
LINACLOTIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2022-06-16
Drug application
- FDA Application #
ANDA211255- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LINACLOTIDE
- Generic name
- Linaclotide
- Active ingredients
- LINACLOTIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- ACTAVIS LABS FL INC
- First approval
- 2022-06-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown